This LinkedIn page is no longer active To view the Rayner Pharmaceuticals LinkedIn Page please click here: https://www.linkedin.com/company/rayner-iol?trk=nav_account_sub_nav_company_admin October 3, 2016 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract surgery, announced today that it has acquired Moorfields Pharmaceuticals. The acquisition closed September 30, 2016. Acquisition details Rayner has acquired Moorfields Pharmaceuticals from Moorfields Eye Hospital NHS Foundation Trust for an undisclosed price, for the purpose of launching a specialist ophthalmic pharmaceuticals division that will be expanded across Rayner’s direct presence in Europe.